切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Synthases/Synthetases - Topoisomerases - Integrin-ligand interactions

21件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. Triacsin C
    B7070 Triacsin C
    Target: Synthases/Synthetases
    Summary: 酰基辅酶A合成酶抑制剂
      Soluble in DMSO
  4. RGD (Arg-Gly-Asp) Peptides
    B3708 RGD (Arg-Gly-Asp) Peptides
     1 Citation
    Target: Integrin-ligand interactions
    Summary: 抑制整合素结合到RGD基序
      insoluble in DMSO
      ≥17.3 mg/mL
  5. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  6. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  7. Mizoribine
    B1472 Mizoribine
    中文名: 咪唑立宾
    Target: Synthases/Synthetases
    Summary: DNA/RNA合成抑制剂
      ≥88.2 mg/mL
      ≥27.6 mg/mL
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  10. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O

21件产品中的 1-10

页面
每页